Author

Sanjay Chanda

OpenAlex ID: A5148734166

1727. Phase 1b Dose-ranging Study Demonstrates Tolerability and Pharmacokinetics (PK) of Oral Epetraborole at the Predicted Therapeutic Dosage for Mycobacterium avium Complex (MAC) Lung Disease

2022 · Paul B Eckburg, Dave Clarke, et al. · Open Forum Infectious Diseases · 6

In Vitro Evaluation of Drug–Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor

2024 · Afshin Shafiee, Sanjay Chanda · Pharmaceuticals · 4

2144. A Phase 1, Multicenter, Open-Label, Parallel-Group Study to Assess the Safety and Pharmacokinetics (PK) of Oral Epetraborole Tablets in Adult Subjects with Varying Degrees of Renal Function

2023 · Gina Patel, George C Canas, et al. · Open Forum Infectious Diseases · 1

MPN-1041: Epetraborole Demonstrates an Exposure-Dependent Effect on Erythropoiesis in Healthy Subjects

2026 · Sanjay Chanda, Alex Smith, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1076: Hematologic and Safety Profile of Epetraborole in a Non-Polycythemia Vera Patient Population

2026 · George H Talbot, Stanton Gerson, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1082: Exposure-Response Analyses of Hemoglobin Changes During Epetraborole Administration to Nonhuman Primates Predict Human Exposure-Response Relationships

2026 · Christopher M Rubino, Jeffrey P Hammel, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1106: Hematological Profile in Nonhuman Primates of Epetraborole, a Novel Boron-Containing Candidate for Oral Treatment of Polycythemia Vera

2026 · Sanjay Chanda, MRK Alley, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1106: Hematological Profile in Nonhuman Primates of Epetraborole, a Novel Boron-Containing Candidate for Oral Treatment of Polycythemia Vera

2026 · Sanjay Chanda, MRK Alley, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1041: Epetraborole Demonstrates an Exposure-Dependent Effect on Erythropoiesis in Healthy Subjects

2026 · Sanjay Chanda, Alex Smith, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1076: Hematologic and Safety Profile of Epetraborole in a Non-Polycythemia Vera Patient Population

2026 · George H Talbot, Stanton Gerson, et al. · Clinical Lymphoma Myeloma & Leukemia

2556. A Phase 1, Open-Label, Single Dose Study to Evaluate the Pharmacokinetics (PK), Safety, and Tolerability of Epetraborole Tablets and the Impact of Alcohol Dehydrogenase (ADH) Genotype on the PK of Epetraborole and Metabolite M3 in Healthy Japanese Adult Subjects

2023 · Gina Patel, Bibiana Castañeda-Ruiz, et al. · Open Forum Infectious Diseases

1716. In Vitro Drug-Drug Interaction Evaluation of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor

2022 · Afshin Shafiee, Bradley K Wong, et al. · Open Forum Infectious Diseases

Works count: 12

Citation count: 11

H-index: 2

I10-index: